Catalyst Pharmaceuticals, Inc.
CPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $52,783 | $52,108 | $56,737 | $55,936 |
| Dep. & Amort. | $9,416 | $9,460 | $9,460 | $9,458 |
| Deferred Tax | $2,417 | -$2,434 | -$2,321 | $2,555 |
| Stock-Based Comp. | $5,670 | $7,597 | $5,850 | $5,171 |
| Change in WC | -$39,623 | $946 | -$7,051 | $4,447 |
| Other Non-Cash | $1,775 | $3,621 | -$2,632 | -$6,690 |
| Operating Cash Flow | $32,438 | $71,298 | $60,043 | $70,877 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$26 | $0 | -$88 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$26 | $0 | -$88 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $2,210 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,654 | -$1,338 | $3,060 | $4,433 |
| Financing Cash Flow | $4,654 | $872 | $3,060 | $4,433 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $37,092 | $72,144 | $63,103 | $75,222 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $652,800 | $580,656 | $517,553 | $442,331 |
| End Cash | $689,892 | $652,800 | $580,656 | $517,553 |
| Free Cash Flow | $32,438 | $71,272 | $60,043 | $70,789 |